Results 151 to 160 of about 1,468,642 (222)

Maximal aerobic speed: methodological implications and unintended consequences. [PDF]

Eur J Appl Physiol
Beltrami FG, Støren Ø, Helgerud J.
europepmc   +1 more source

Ruxolitinib for rheumatic disease-associated macrophage activation syndrome in children: a retrospective cohort study. [PDF]

Front Immunol
Zhu X, Zhang M, Yang J, He T.
europepmc   +1 more source

Relationship Between Macrophage Arc and Plaque Vulnerability in Patients With Coronary Artery Disease. [PDF]

JACC Adv
Ou Z, Qu X, Cui B, Xie L, Wang K, Xiao H, Ma Y, Zhao M, Qiu Y, Zhang Y, Qian D, Zhang Z, Liu B, Zhao X.   +13 more
europepmc   +1 more source

Small extracellular vesicles induced by Angiotensin-(1-7) enhance cardioprotection following myocardial ischemia-reperfusion injury. [PDF]

Mol Cell Biochem
Wu Y, Wang X, Zhao J, Yang H, Zhang W, Yao Z, Sun Y, Wang Y, Liang B, Yang Z.   +9 more
europepmc   +1 more source

Mejorar el funcionamiento de la atención primaria de salud: HEARTS 2.0 ofrece una gran oportunidad para integrar la atención cardiovascular, renal y metabólica. [PDF]

Rev Panam Salud Publica
Ordúñez P, da Silva JB.
europepmc   +1 more source

Development of a predictive tool for hemophagocytic lymphohistiocytosis/macrophage activation syndrome risk in adult-onset Still's disease. [PDF]

Front Immunol
Hong X, Meng L, Dai N, Shi H, Su Y, Hu Q, Sun Y, Liu H, Meng J, Jia J, Wang M, Yang C, Wu Y, Teng J, Chi H.   +14 more
europepmc   +1 more source

Orthopaedic diagnostic pitfalls in fibroblast growth factor 23-mediated hypophosphatemic rickets/osteomalacia in fibrous dysplasia/McCune-Albright syndrome: Two burosumab-treated cases. [PDF]

Bone Rep
Nakagawa T, Imanishi J, Koda A, Matsuyama T, Sato K, Yamamoto A, Matsui K, Watanabe Y, Kawano H.   +8 more
europepmc   +1 more source